Continuing its commitment to medical industry, Arkema launches Pebax MED resins for medical device applications. These grades represent the highest quality of Pebax polymers for medical applications, including devices exposed short term to bodily fluids (<30 days). Effective January 1, 2011 Arkema will no longer offer standard grade Pebax SA resins for any medical applications.
Pebax resin has been a preferred material in medical devices, such as minimally invasive catheters for angioplasty, since the mid 1990’s. Pebax resin has gained recognition over other elastomers for excellent flexibility, kink resistance, torque transfer, and low coefficient of friction. Over recent years however, the functional and processing requirements for polymers have become more rigorous Arkema is introducing this new Pebax grade as part of an ongoing commitment to the medical industry, offering a range of grades specifically intended for today’s devices.
“Our highest quality Pebax MED resin will be instrumental in helping OEMs meet the growing demands of minimally invasive and intravascular devices by improving product performance and manufacturing yields,” says Basker Lalgudi, Arkema’s North American Medical Market Manager.
All Pebax MED resin grades have passed USP Class VI biocompatibility testing and are sterilizable by EtO, gamma and steam, key requirements for minimally invasive devices. Pebax chemistries are also available in breathable films suitable for thick coatings or laminates used in level 3 and 4 medical apparel applications, such as surgical gowns, masks, gloves, drapes and wound dressings.
Get curated news on YOUR industry.
Enter your email to receive our newsletters.Latest from Today's Medical Developments
- AI will power the next generation of medical wearables
- CUI Crash Course from Smithers
- Revolutionary implant harnesses electricity for healing
- Discover the advantages of Oerlikon's latest Surface Two technology
- #48 Lunch + Learn Podcast with OPEN MIND Technologies
- CERATIZIT achieves SBTi validation for emissions goals
- Applied Motion Products’ MLA & MEA series linear actuators
- Arterex expands portfolio with Xponent Global acquisition